The Supreme Court ruled 6-3 that President Trump's sweeping global tariffs were unconstitutional, finding that the International Emergency Economic Powers Act does not authorize the president to impose tariffs without clear congressional authorization. The decision triggered a sharp rally across U.S. equities, with 10 stocks posting significant gains following the ruling that invalidates tariffs that had reached up to 145% on some products.

U.S. stock futures rose on Friday ahead of Q4 GDP data and PCE inflation gauge releases. Markets are pricing in a 94% likelihood of unchanged Fed rates in March. Notable movers include Copart missing earnings expectations, Comfort Systems raising dividends, Grail plunging 47% on weak earnings, Candel Therapeutics declining on stock offering announcement, and Dropbox falling despite beating earnings. Wells Fargo strategist recommends leaning into growth-sensitive sectors like Financials and Industrials rather than defensive positioning.

Copart (NASDAQ: CPRT) stock dropped significantly in after-hours trading following Q2 earnings that missed analyst expectations. The company reported EPS of 36 cents versus the consensus estimate of 40 cents, and quarterly revenue of $1.12 billion fell short of the $1.14 billion estimate and declined year-over-year from $1.16 billion. Shares fell 11.16% in after-hours trading.

Weybosset Research & Management LLC fully exited its position in MaxLinear on January 6, 2026, selling all 205,893 shares worth approximately $3.31 million. The exit reflects MaxLinear's poor performance, with stock down 42% from early 2023 and revenue declining 62% over three years, while the company has shifted from $101 million in net income in 2022 to a $180 million net loss.

Top investors like Warren Buffett, Bill Gates, and others revealed their third-quarter stock purchases and investment strategies, highlighting key moves in the market.

Argent Capital Management significantly reduced its Copart stake by selling 1,262,984 shares in Q3 2025, leaving only 0.2% of its portfolio allocation, potentially signaling concerns about the company's recent performance and valuation.

Copart reported Q4 earnings of $0.41 per share on $1.13 billion in sales, showing 5% sales and 24% profit growth. However, the stock price dropped due to slowing growth rates and concerns about its high valuation multiple.

Copart reported strong Q4 fiscal 2025 financial results, with 24.2% EPS growth, 5.2% revenue increase, and operational improvements across service revenue, net income, and global auction platform expansion.

The article highlights three stocks with near-monopoly market positions in their respective industries: Copart, ASML Holding, and Fair Isaac Corporation. These companies have significant market share, minimal competition, and potential for investor returns despite trading below their 52-week highs.

Copart, the leading online auction platform for totaled vehicles, has seen a recent 20% decline in its share price, presenting a buying opportunity for investors. The company's strong market position, technological advantages, and financial strength make it an attractive long-term investment.

Several large-cap stocks, including PDD Holdings, Regeneron Pharmaceuticals, and Burlington Stores, were among the top losers last week, with declines ranging from 11.9% to 29.3%. The reasons for the losses varied, from mixed clinical trial results to earnings misses and tariff concerns.

U.S. equities posted broad-based gains on Tuesday, driven by a drop in Treasury yields and renewed optimism surrounding trade talks between the U.S. and the European Union. The S&P 500 rose 1.9%, extending May's gains to more than 6%, while technology and small-cap stocks outpaced broader benchmarks.